Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOCARES: EPO in Cardiorenal Syndrome
NCT00356733Phase 3Completed
- Start
- Jan 2007
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in cardiorenal syndrome (CRS). Started Jan 2007; status: completed.
02
Drugs
erythropoietin
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT00356733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356733.